Ki67, a marker associated with cell proliferation, can distinguish luminal B breast cancer, which is associated with poor recurrence-free and disease-specific survival, from luminal A tumors at the cut point of 14% [46]. This evidence concerns the gene MKI67 and breast carcinoma.